Studies demonstrate improved safety results achieved with investigational drug for hep B

Posted by on April 15, 2016 12:13 pm
Categories: health

Studies demonstrate that tenofovir alafenamide (TAF) improves patient safety while maintaining efficacy in patients with chronic hepatitis B virus (HBV) infection compared to tenofovir disoproxil fumarate (Viread, TDF).

Leave a Reply

Your email address will not be published. Required fields are marked *